Related Experiment Video
Updated: Sep 13, 2025

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Human amylin is a potent antimicrobial peptide that exhibits antimicrobial synergism with the amyloid beta protein
Deepak K Vijaya Kumar1, Teryn A Mitchell1, Breeya A Tailor1
1Genetics and Aging Research Unit, Henry and Allison McCance Center for Brain Health, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts, USA.
Introduction:
Our previous studies demonstrated the antimicrobial properties of amyloid beta (Aβ) of Alzheimer's disease (AD) against clinically relevant bacteria, yeast, and viruses. In this study, we investigate the antimicrobial function of the 37-amino acid amylin of type 2 diabetes (T2D), expanding on its potential involvement in AD.
Methods:
We used in vitro assays, including human three-dimensional neuronal cell culture models, to test microbicidal, microbiostatic, and synergistic antimicrobial interactions between amylin and Aβ against microbes.
Results:
Our results confirm that amylin is a broad-spectrum antimicrobial peptide that exhibits both microbicidal and microbiostatic mechanisms. We also identified a synergistic antimicrobial effect between amylin and Aβ in inhibiting Salmonella Typhimurium and Staphylococcus aureus.
Discussion:
The findings show that amylin is an antimicrobial peptide and functions synergistically with Aβ against bacterial pathogens. Increased amylin secretion after bacterial infection suggests a broader biological role for amylin beyond its involvement in T2D.
Highlights:
Amylin is a potent antimicrobial peptide, eliminating ≥99.9% bacteria at low doses. Amylin efficiently traps and neutralizes microbes via a fibril-driven mechanism. Amylin protects human cells and Caenorhabditis elegans from Salmonella or Candida infection. Synthetic amylin and amyloid beta (Aβ) together amplify antibacterial response against bacteria. Synergy between cell-derived amylin and Aβ drives dynamic antimicrobial activity against neural infection.
Insights
Amylin, a peptide linked to type 2 diabetes, acts as a potent antimicrobial agent. It works synergistically with amyloid beta (Aβ) to fight bacterial infections, suggesting a broader role in immunity.
Area of Science:
- Neuroscience
- Immunology
- Endocrinology
Background:
- Previous research identified antimicrobial properties of amyloid beta (Aβ) in Alzheimer's disease (AD).
- This study investigates the antimicrobial function of amylin, a peptide associated with type 2 diabetes (T2D).
Purpose of the Study:
- To determine the antimicrobial activity of amylin.
- To explore the synergistic antimicrobial effects of amylin and Aβ.
- To expand understanding of amylin's biological role beyond T2D and its potential involvement in AD.
Main Methods:
- In vitro assays were employed.
- Human three-dimensional neuronal cell culture models were utilized.
- Microbicidal, microbiostatic, and synergistic antimicrobial interactions between amylin and Aβ against microbes were tested.
Main Results:
- Amylin demonstrated broad-spectrum antimicrobial activity, acting as both a microbicidal and microbiostatic agent.
- A synergistic antimicrobial effect between amylin and Aβ was observed against Salmonella Typhimurium and Staphylococcus aureus.
- Amylin was found to be a potent antimicrobial peptide, eliminating ≥99.9% of bacteria at low doses.
- Amylin protects human cells and Caenorhabditis elegans from Salmonella or Candida infection.
Conclusions:
- Amylin is confirmed as a potent antimicrobial peptide with a fibril-driven mechanism for trapping and neutralizing microbes.
- Amylin functions synergistically with Aβ against bacterial pathogens, amplifying the antimicrobial response.
- Increased amylin secretion post-infection suggests a significant biological role in host defense, extending beyond its known association with T2D.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Gene Regulation in Microbial Communities: Quorum Sensing

